One-shot Ovarian Stimulation Protocol (One-shot)
One-Shot Ovarian Stimulation Protocol: A Pilot Study Investigating the Endocrine Profile
Fundación Santiago Dexeus Font
20 participants
Oct 31, 2024
INTERVENTIONAL
Conditions
Summary
The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).
Eligibility
Inclusion Criteria4
- Age <= 40
- AMH (Anti-Mullerian Hormone) 1.2-3.5 ng/ml or AFC 7-20
- No family history of hereditary or chromosomal diseases
- Body mass index (BMI) 18 to 30 kg/m2
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
On day 2 or 3 of the menstrual cycle or after 5 days of pill-free interval, a single injection of 150 mcg of CFA (Stimulation Day 1) will be administered.
On day 2 or 3 of the menstrual cycle or after 5 days of pill-free interval, the patients will start oral administration of Clomiphene Citrate 100/day continuing up to and including the day of ovulation triggering
Scan controls and blood exams will be performed on stimulation days 1, 6, 8, 10 and, according to clinical needs, until trigger day.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06635538